Eaderm

1 known investors

EADERM develops pharmaceuticals and functional products based on protection and control technologies for skin and hair tissue stem cells. Its R&D targets novel treatments for alopecia, pressure ulcers, and rare intractable diseases such as premature aging syndromes.

BiotechHealthtechLongevity